| Total | Collapse | Non-collapse | P value |
---|---|---|---|---|
n | n/% | n/% | ||
Number of hips | 202 | 98/48.5 | 104/51.5 | Â |
Age (x ± s) | 52.48 ± 12.18 | 47.60 ± 12.57 | 0.006a** |  |
BMI (x ± s) | 23.03 ± 2.76 | 22.90 ± 2.47 | 0.725a |  |
Sex | Â | Â | Â | 0.426b |
 Male | 141 | 71/35.1 | 70/34.7 |  |
 Female | 61 | 27/13.4 | 34/16.8 |  |
Invasive hip | Â | Â | Â | 0.473b |
 Unilateral | 52 | 23/11.4 | 29/14.4 |  |
 Bilateral | 150 | 75/37.1 | 75/37.1 |  |
Etiology | Â | Â | Â | 0.608b |
 Idiopathic | 100 | 52/25.7 | 48/23.8 |  |
 Glucocorticoid | 79 | 36/17.8 | 43/21.3 |  |
 Alcohol | 23 | 10/5.0 | 13/6.4 |  |
ARCO staging | Â | Â | Â | 0.000b*** |
 Stage I | 40 | 4/2.0 | 36/17.8 |  |
 Stage II | 162 | 94/46.5 | 68/33.7 |  |
JIC classification | Â | Â | Â | 0.000b*** |
 Type A | 19 | 2/1.0 | 17/8.4 |  |
 Type B | 54 | 16/7.9 | 38/18.8 |  |
 Type C1 | 86 | 48/23.8 | 38/18.8 |  |
 Type C2 | 43 | 32/15.8 | 11/5.4 |  |
Area | Â | Â | Â | 0.000b*** |
 < 30% | 91 | 30/14.9 | 61/30.2 |  |
 30–50% | 77 | 40/19.8 | 39/19.3 |  |
 > 50% | 34 | 28/13.9 | 4/2.0 |  |